What are Chaya Eri’s RH share holdings after these transactions?

After the reported option exercise and sales, no direct common stock holdings are shown for Eri. The Form 4 reports 23,643 RH shares held indirectly by the Chaya-Smith Revocable Trust , reflecting her remaining reported beneficial interest.

RH (RH) director exercises options and sells 7,000 shares under plan

Q: What did RH director Chaya Eri report in this Form 4 for RH?

Chaya Eri reported exercising 7,000 stock options at $39.42 per share and selling 7,000 common shares in open-market trades. The filing also shows indirect ownership of 23,643 shares held by the Chaya-Smith Revocable Trust .

Q: How many RH shares did Chaya Eri sell, and at what prices?

She sold a total of 7,000 RH common shares in four open-market transactions. Weighted average sale prices ranged from about $127.96 to $130.74 per share, with individual trades executed within price ranges disclosed in the detailed footnotes.

Q: What options did Chaya Eri exercise in RH according to the Form 4?

Eri exercised 7,000 stock options to buy RH common stock at an exercise price of $39.42 per share. A footnote notes that this option award is fully vested and exercisable , and all 7,000 underlying shares were acquired and then sold.

Q: Was the RH stock sale by Chaya Eri under a Rule 10b5-1 plan?

Yes. A footnote states the sales were effected under a Rule 10b5-1 trading plan adopted on October 7, 2024. Such plans pre-schedule trades, indicating these dispositions were made pursuant to an established trading arrangement.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

RH director and officer Chaya Eri reported an option exercise and related share sales. Eri exercised 7,000 stock options at an exercise price of $39.42 per share, receiving 7,000 shares of common stock. On the same day, she sold 7,000 common shares in multiple open-market transactions at weighted average prices between roughly $127.96 and $130.74 per share, under a pre-arranged Rule 10b5-1 trading plan adopted on October 7, 2024. Following these transactions, no direct common stock holdings are reported, while 23,643 shares are reported as held indirectly by the Chaya-Smith Revocable Trust.

Insider Trade Summary

Net Seller: 7,000 shares ($905,950)

Net Sell 7 txns

Insider Chaya Eri

Role SEE REMARKS

Sold 7,000 shs ($906K)

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	7,000	$0.00	--
Exercise	Common Stock	7,000	$39.42	$276K
Sale	Common Stock	822	$127.9594	$105K
Sale	Common Stock	2,483	$128.7428	$320K
Sale	Common Stock	2,177	$129.8314	$283K
Sale	Common Stock	1,518	$130.7354	$198K
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 36,000 shares (Direct); Common Stock — 7,000 shares (Direct); Common Stock — 23,643 shares (Indirect, By Trust)

Footnotes (1)

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. This transaction was executed in multiple trades ranging from $127.27 to $128.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. This transaction was executed in multiple trades ranging from $128.29 to $129.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. This transaction was executed in multiple trades ranging from $129.30 to $130.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. This transaction was executed in multiple trades ranging from $130.38 to $131.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Held by the Chaya-Smith Revocable Trust. This option award is fully vested and exercisable.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

03/25/2026 - 08:00 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chaya Eri

(Last)

(First)

(Middle)

C/O RH

15 KOCH ROAD, SUITE K

(Street)

CORTE MADERA

CALIFORNIA

94925

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RH [ RH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SEE REMARKS

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/24/2026		M		7,000	A	$39.42	7,000	D
Common Stock	03/24/2026		S		822	D	$127.9594⁽¹⁾⁽²⁾	6,178	D
Common Stock	03/24/2026		S		2,483	D	$128.7428⁽¹⁾⁽³⁾	3,695	D
Common Stock	03/24/2026		S		2,177	D	$129.8314⁽¹⁾⁽⁴⁾	1,518	D
Common Stock	03/24/2026		S		1,518	D	$130.7354⁽¹⁾⁽⁵⁾	0	D
Common Stock								23,643	I	By Trust⁽⁶⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$39.42	03/24/2026		M			7,000	⁽⁷⁾	05/03/2026	Common Stock	7,000	$0	36,000	D

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024.

2. This transaction was executed in multiple trades ranging from $127.27 to $128.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

3. This transaction was executed in multiple trades ranging from $128.29 to $129.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

4. This transaction was executed in multiple trades ranging from $129.30 to $130.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

5. This transaction was executed in multiple trades ranging from $130.38 to $131.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

6. Held by the Chaya-Smith Revocable Trust.

7. This option award is fully vested and exercisable.

Remarks:

President, Co-Chief Creative and Merchandising Officer and Director

	/s/ Jill Falor, Attorney-in-Fact	03/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did RH director Chaya Eri report in this Form 4 for RH?

Chaya Eri reported exercising 7,000 stock options at $39.42 per share and selling 7,000 common shares in open-market trades. The filing also shows indirect ownership of 23,643 shares held by the Chaya-Smith Revocable Trust.

How many RH shares did Chaya Eri sell, and at what prices?

She sold a total of 7,000 RH common shares in four open-market transactions. Weighted average sale prices ranged from about $127.96 to $130.74 per share, with individual trades executed within price ranges disclosed in the detailed footnotes.

What options did Chaya Eri exercise in RH according to the Form 4?

Eri exercised 7,000 stock options to buy RH common stock at an exercise price of $39.42 per share. A footnote notes that this option award is fully vested and exercisable, and all 7,000 underlying shares were acquired and then sold.

Was the RH stock sale by Chaya Eri under a Rule 10b5-1 plan?

Yes. A footnote states the sales were effected under a Rule 10b5-1 trading plan adopted on October 7, 2024. Such plans pre-schedule trades, indicating these dispositions were made pursuant to an established trading arrangement.

How many RH derivative securities remain for Chaya Eri after this Form 4?

The derivative summary in the data provided is empty, indicating no remaining derivative positions are reported in this Form 4. The filing shows one option exercise of 7,000 options, with all underlying shares acquired and then sold on the same date.